Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02467296 · ClinicalTrials.gov registry record · NA

Dietary Sodium Intake and Outcomes in Heart Failure

A NA study, sponsored by Stony Brook University.

Completed
Registry status
NA
Development phase
27
Enrollment target

NCT02467296 is a NA study that has completed, run by Stony Brook University. The registered enrollment target is 27 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02467296, a NA study, has completed, sponsored by Stony Brook University.

COMPLETED
Registry status
NA
Development phase
27 participants
Enrollment target

Study Summary

Currently, the recommendations for sodium intake restriction for patients with heart failure are mostly based on expert consensus and observational evidence, whereas smaller randomized studies have actually suggested that strict dietary sodium reduction may be harmful in heart failure. In the present clinical trial pilot study, the investigators plan to collect data on enrollment rates, compliance, outcomes, and safety of a 12-week dietary intervention in heart failure patients, with prepared food containing two different levels of sodium (1,500 mg and 3,000 mg) daily, followed by a 12-week surveillance for safety and effectiveness. The goal is to inform the design of a fullscale clinical trial that will provide more definitive evidence for dietary sodium recommendations in heart failure.

Interventions

  • OTHER Dietary plan with controlled amount of Sodium

Trial Details

FieldValue
Enrollment Target 27 participants
Start Date 2015-02
Est. Completion 2018-11
Phase NA

Sponsor

Stony Brook University

127 total trials

What the Registry Record Tells You About NCT02467296

The ClinicalTrials.gov registry entry for NCT02467296 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stony Brook University, which has 127 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Dietary plan with controlled amount of Sodium is the first listed.

NCT02467296 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02467296 about?

NCT02467296 is a clinical study titled "Dietary Sodium Intake and Outcomes in Heart Failure". Currently, the recommendations for sodium intake restriction for patients with heart failure are mostly based on expert consensus and observational evidence, whereas smaller randomized studies have actually suggested that strict dietary sodium reduction may be harmful in heart failure. In the presen...

What is the current status of trial NCT02467296?

This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2015-02. Estimated completion is 2018-11.

What interventions are being tested in trial NCT02467296?

The interventions under investigation include: Dietary plan with controlled amount of Sodium (OTHER).

Who is sponsoring clinical trial NCT02467296?

This trial is sponsored by Stony Brook University, which has 127 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.